Zomedica Pharmaceuticals Corp Stock Price Prediction
| ZOM Stock | USD 0.13 0.01 7.14% |
Oversold Vs Overbought
76
Oversold | Overbought |
Wall Street Target Price 0.25 | Quarterly Revenue Growth 0.018 |
Using Zomedica Pharmaceuticals hype-based prediction, you can estimate the value of Zomedica Pharmaceuticals Corp from the perspective of Zomedica Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Zomedica Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Zomedica because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Zomedica Pharmaceuticals after-hype prediction price | USD 0.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Zomedica |
Zomedica Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Zomedica Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zomedica Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Zomedica Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Zomedica Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Zomedica Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zomedica Pharmaceuticals' historical news coverage. Zomedica Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 4.25, respectively. We have considered Zomedica Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Zomedica Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Zomedica Pharmaceuticals is based on 3 months time horizon.
Zomedica Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Zomedica Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zomedica Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zomedica Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 4.12 | 0.00 | 0.02 | 4 Events / Month | 11 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.13 | 0.13 | 0.00 |
|
Zomedica Pharmaceuticals Hype Timeline
On the 18th of January 2025 Zomedica Pharmaceuticals is traded for 0.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Zomedica is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.21%. %. The volatility of related hype on Zomedica Pharmaceuticals is about 5539.5%, with the expected price after the next announcement by competition of 0.11. The company has Price to Book (P/B) ratio of 0.61. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zomedica Pharmaceuticals recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. Considering the 90-day investment horizon the next estimated press release will be in about 4 days. Check out Zomedica Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Zomedica Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Zomedica Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Zomedica Pharmaceuticals' future price movements. Getting to know how Zomedica Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zomedica Pharmaceuticals may potentially react to the hype associated with one of its peers.
Zomedica Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Zomedica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zomedica using various technical indicators. When you analyze Zomedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Zomedica Pharmaceuticals Predictive Indicators
The successful prediction of Zomedica Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Zomedica Pharmaceuticals Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Zomedica Pharmaceuticals based on analysis of Zomedica Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Zomedica Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zomedica Pharmaceuticals's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 35.94 | 31.85 | 36.63 | 49.64 | PTB Ratio | 0.6 | 0.82 | 0.94 | 0.89 |
Story Coverage note for Zomedica Pharmaceuticals
The number of cover stories for Zomedica Pharmaceuticals depends on current market conditions and Zomedica Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zomedica Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zomedica Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Zomedica Pharmaceuticals Short Properties
Zomedica Pharmaceuticals' future price predictability will typically decrease when Zomedica Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zomedica Pharmaceuticals Corp often depends not only on the future outlook of the potential Zomedica Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zomedica Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 979.9 M | |
| Cash And Short Term Investments | 90.5 M |
Check out Zomedica Pharmaceuticals Basic Forecasting Models to cross-verify your projections. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth 0.018 | Return On Assets | Return On Equity |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.